171 related articles for article (PubMed ID: 22828545)
1. Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia.
Khan TH; Shahidullah M; Mannan MA; Nahar N
Mymensingh Med J; 2012 Jul; 21(3):469-74. PubMed ID: 22828545
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
Gathwala G; Walia M; Bala H; Singh S
J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
[TBL] [Abstract][Full Text] [Related]
3. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
4. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
[TBL] [Abstract][Full Text] [Related]
5. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.
Bedford Russell AR; Emmerson AJ; Wilkinson N; Chant T; Sweet DG; Halliday HL; Holland B; Davies EG
Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F172-6. PubMed ID: 11320043
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two regimens of RhG-CSF in neutropenic neonatal septicemia: a randomized clinical trial.
Nayeri F; Soheili H; Kaveh M; Oloomi Yazdi Z; Shariat M; Dalili H
Acta Med Iran; 2011; 49(9):575-8. PubMed ID: 22052139
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
8. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
Ahmad M; Fleit HB; Golightly MG; La Gamma EF
Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
[TBL] [Abstract][Full Text] [Related]
9. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis.
Zuppa AA; Girlando P; Florio MG; Cota F; Romagnoli C; Tortorolo G
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):131-6. PubMed ID: 11950479
[TBL] [Abstract][Full Text] [Related]
10. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia.
Teng RJ; Wu TJ; Sharma R; Garrison RD; Hudak ML
J Formos Med Assoc; 2015 Feb; 114(2):174-9. PubMed ID: 25678180
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
[TBL] [Abstract][Full Text] [Related]
13. The in vivo effect of recombinant human granulocyte-colony stimulating factor in neutropenic neonates with sepsis.
Barak Y; Leibovitz E; Mogilner B; Juster-Reicher A; Amitay M; Ballin A; Koren A; Goebel M
Eur J Pediatr; 1997 Aug; 156(8):643-6. PubMed ID: 9266199
[TBL] [Abstract][Full Text] [Related]
14. A randomized case-controlled study of recombinant human granulocyte colony stimulating factor for the treatment of sepsis in preterm neutropenic infants.
Aktaş D; Demirel B; Gürsoy T; Ovalı F
Pediatr Neonatol; 2015 Jun; 56(3):171-5. PubMed ID: 25458637
[TBL] [Abstract][Full Text] [Related]
15. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
Ahmad A; Laborada G; Bussel J; Nesin M
Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia.
Ishikawa K; Tanaka H; Matsuoka T; Shimazu T; Yoshioka T; Sugimoto H
J Trauma; 1998 Jun; 44(6):1047-54; discussion 1054-5. PubMed ID: 9637161
[TBL] [Abstract][Full Text] [Related]
17. In vivo effect of recombinant human granulocyte colony-stimulating factor on neutrophilic expression of CD11b in septic neonates: a randomized controlled trial.
El-Ganzoury MM; El-Farrash RA; Saad AA; Mohamed AG; El-Sherbini IG
Pediatr Hematol Oncol; 2012 Apr; 29(3):272-84. PubMed ID: 22475305
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
19. Difference in the responses after administration of granulocyte colony-stimulating factor in septic patients with relative neutropenia.
Ishikawa K; Tanaka H; Nakamori Y; Hosotsubo H; Ogura H; Nishino M; Shimazu T; Sugimoto H
J Trauma; 2000 May; 48(5):814-24; discussion 824-5. PubMed ID: 10823524
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
Carr R; Brocklehurst P; Doré CJ; Modi N
Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]